Khalil Helou
Khalil Helou
associate professor, docent, university of gothenburg
Verifierad e-postadress på oncology.gu.se
Citeras av
Citeras av
Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome
E Shubbar, A Kovács, S Hajizadeh, TZ Parris, S Nemes, K Gunnarsdóttir, ...
BMC cancer 13, 1-10, 2013
Clinical implications of gene dosage and gene expression patterns in diploid breast carcinoma
TZ Parris, A Danielsson, S Nemes, A Kovács, U Delle, G Fallenius, ...
Clinical Cancer Research 16 (15), 3860-3874, 2010
Optimization of cell viability assays to improve replicability and reproducibility of cancer drug sensitivity screens
P Larsson, H Engqvist, J Biermann, E Werner Rönnerman, ...
Scientific reports 10 (1), 5798, 2020
Validity and reliability of an adapted arabic version of the long international physical activity questionnaire
K Helou, N El Helou, M Mahfouz, Y Mahfouz, P Salameh, ...
BMC public health 18 (1), 1-8, 2018
Overexpression of the hepatocyte growth factor (HGF) receptor (Met) and presence of a truncated and activated intracellular HGF receptor fragment in locally aggressive …
V Wallenius, M Hisaoka, K Helou, G Levan, N Mandahl, ...
The American journal of pathology 156 (3), 821-829, 2000
A review of organochlorine pesticides and polychlorinated biphenyls in Lebanon: Environmental and human contaminants
K Helou, M Harmouche-Karaki, S Karake, JF Narbonne
Chemosphere 231, 357-368, 2019
Rat–mouse and rat–human comparative maps based on gene homology and high-resolution zoo-FISH
S Nilsson, K Helou, A Walentinsson, C Szpirer, O Nerman, F Ståhl
Genomics 74 (3), 287-298, 2001
Nuclear Janus-activated kinase 2/nuclear factor 1-C2 suppresses tumorigenesis and epithelial-to-mesenchymal transition by repressing Forkhead box F1
J Nilsson, K Helou, A Kovács, PO Bendahl, G Bjursell, M Fernö, ...
Cancer research 70 (5), 2020-2029, 2010
Clinical relevance of breast cancer-related genes as potential biomarkers for oral squamous cell carcinoma
TZ Parris, L Aziz, A Kovács, S Hajizadeh, S Nemes, M Semaan, CY Chen, ...
BMC cancer 14, 1-11, 2014
Frequent MYC coamplification and DNA hypomethylation of multiple genes on 8q in 8p11-p12-amplified breast carcinomas
TZ Parris, A Kovacs, S Hajizadeh, S Nemes, M Semaan, M Levin, ...
Oncogenesis 3 (3), e95-e95, 2014
Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer
HJ Johansson, BC Sanchez, F Mundt, J Forshed, A Kovacs, E Panizza, ...
Nature communications 4 (1), 2175, 2013
Gene-based anchoring of the rat genetic linkage and cytogenetic maps: new regional localizations, orientation of the linkage groups, and insights into mammalian chromosome …
C Szpirer, J Szpirer, P Van Vooren, F Tissir, JS Simon, G Koike, HJ Jacob, ...
Mammalian genome 9, 721-734, 1998
Additive effect of the AZGP1, PIP, S100A8 and UBE2C molecular biomarkers improves outcome prediction in breast carcinoma
TZ Parris, A Kovács, L Aziz, S Hajizadeh, S Nemes, M Semaan, ...
International journal of cancer 134 (7), 1617-1629, 2014
Trends in nutritional intakes and nutrition-related cardiovascular disease risk factors in Lebanon: the need for immediate action
L Nasreddine, F Naja, AM Sibai, K Helou, N Adra, N Hwalla
Lebanese Medical Journal 103 (1151), 1-9, 2014
Analysis of cytogenetic alterations in stage III serous ovarian adenocarcinoma reveals a heterogeneous group regarding survival, surgical outcome, and substage
K Partheen, K Levan, L Österberg, K Helou, G Horvath
Genes, Chromosomes and Cancer 40 (4), 342-348, 2004
Characterization and chromosomal localization of rat scavenger receptor class B type I, a high density lipoprotein receptor with a putative leucine zipper domain and …
MSC Johnson, PA Svensson, K Helou, H Billig, G Levan, LMS Carlsson, ...
Endocrinology 139 (1), 72-80, 1998
Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer
E Karlsson, U Delle, A Danielsson, B Olsson, F Abel, P Karlsson, K Helou
Bmc Cancer 8 (1), 1-14, 2008
Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas
H Engqvist, TZ Parris, A Kovács, S Nemes, E Werner Rönnerman, ...
BMC cancer 19, 1-12, 2019
High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer
E Shubbar, K Helou, A Kovács, S Nemes, S Hajizadeh, C Enerbäck, ...
BMC cancer 13 (1), 1-12, 2013
Up-regulation of cell cycle arrest protein BTG2 correlates with increased overall survival in breast cancer, as detected by immunohistochemistry using tissue microarray
E Möllerström, A Kovács, K Lövgren, S Nemes, U Delle, A Danielsson, ...
BMC cancer 10 (1), 1-11, 2010
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20